A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia Post author: Post published:September 6, 2026 Post category: Continue ReadingA first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia
Microglia replacement therapy for CSF1R-related Leukoencephalopathy Post author: Post published:September 6, 2026 Post category: Continue ReadingMicroglia replacement therapy for CSF1R-related Leukoencephalopathy
TY1 and Semaglutide to Treat Cardiometabolic HFpEF Post author: Post published:September 6, 2026 Post category: Continue ReadingTY1 and Semaglutide to Treat Cardiometabolic HFpEF
CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia Post author: Post published:September 6, 2026 Post category: Continue ReadingCRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia
Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy Post author: Post published:September 6, 2026 Post category: Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy
Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders Post author: Post published:September 6, 2026 Post category: Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders
Stem Cell-Based Cartilage Tissue Regeneration Post author: Post published:September 6, 2026 Post category: Continue ReadingStem Cell-Based Cartilage Tissue Regeneration
Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence Post author: Post published:September 6, 2026 Post category: Continue ReadingAutologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence
Transplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders Post author: Post published:September 6, 2026 Post category: Continue ReadingTransplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders
Advancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders Post author: Post published:September 6, 2026 Post category: Continue ReadingAdvancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders
